Literature DB >> 8872958

Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.

C A Rankin1, K Suzuki, Y Itoh, D M Ziemer, J J Grantham, J P Calvet, H Nagase.   

Abstract

Restructuring of basement membranes is a hallmark of the pathology of renal cystic disorders. Here, we present findings consistent with the view that basement membrane degradation by matrix metallo-proteinases (MMPs) may contribute to abnormal basement membrane structure in polycystic kidney disease. Cells from cystic kidney tubules embedded in collagen gels appeared to migrate through the gel. This migration through collagen indicated that these cells could degrade the matrix. To examine this activity, we cultured cystic kidney tubules derived from the C57BL/6J cpk/cpk mouse, a hereditary model of polycystic kidney disease, and assayed conditioned medium for the presence of MMPs and tissue inhibitors of metalloproteinases (TIMPs). The conditioned medium from the cystic tubules contained higher than normal levels of MMP-9, MMP-2, and MMP-3 as well as TIMP-1 and TIMP-2. A 101 kDa protease was present equally in cystic and control cultures and although inhibited by EDTA, it was not inhibited by TIMPs, nor activated by the mercurial compound APMA. These data suggest that cystic kidney tubules synthesize and secrete high levels of MMPs which may then participate in the restructuring of the tubular basement membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872958     DOI: 10.1038/ki.1996.383

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Polycystic kidney disease: huge kidneys, huge problems, huge progress.

Authors:  J J Grantham
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

2.  Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.

Authors:  David R Emlet; Nuria Pastor-Soler; Allison Marciszyn; Xiaoyan Wen; Hernando Gomez; William H Humphries; Seth Morrisroe; Jacob K Volpe; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

3.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

Review 4.  Drug discovery for polycystic kidney disease.

Authors:  Ying Sun; Hong Zhou; Bao-xue Yang
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 5.  Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Jill Norman
Journal:  Biochim Biophys Acta       Date:  2011-07-01

Review 6.  Novel targets for the treatment of autosomal dominant polycystic kidney disease.

Authors:  Franck A Belibi; Charles L Edelstein
Journal:  Expert Opin Investig Drugs       Date:  2010-03       Impact factor: 6.206

7.  Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.

Authors:  K L Andrews; T Betsuyaku; S Rogers; J M Shipley; R M Senior; J H Miner
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Doxycycline accelerates renal cyst growth and fibrosis in the pcy/pcy mouse model of type 3 nephronophthisis, a form of recessive polycystic kidney disease.

Authors:  Larissa Osten; Marion Kubitza; Anna Rachel Gallagher; Jürgen Kastner; Heike Olbrich; Uwe de Vries; Frieder Kees; Brigitte Lelongt; Stefan Somlo; Heymut Omran; Ralph Witzgall
Journal:  Histochem Cell Biol       Date:  2009-04-21       Impact factor: 4.304

Review 9.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis.

Authors:  Eduard Condac; Robert Silasi-Mansat; Stanley Kosanke; Trenton Schoeb; Rheal Towner; Florea Lupu; Richard D Cummings; Myron E Hinsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.